IPOGrid
0001625297
IPO filing research
Indivior Pharmaceuticals, Inc.
Pharmaceutical Preparations · INDV
ipo
trading
priced
Nasdaq
424B3
Indivior Pharmaceuticals, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: 424B3 on 2026-09-11. Current deal snapshot: exchange Nasdaq.
Filing Timeline
SEC EDGAR
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
First tracked pre-IPO filing for this issuer.
2026-09-11 · 0001104659-26-107070
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-09-09 · 0001104659-26-106390
S-4
filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
Use of proceeds to pay financial advisory fees and expenses
2026-08-28 · 0001104659-26-103278
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-08-04 · 0001193125-26-331036
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-08-03 · 0001193125-26-330875
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-08-03 · 0001193125-26-329620
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-08-03 · 0001193125-26-329521
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 20-F in the pre-IPO sequence.
2026-08-03 · 0001193125-26-329517
20-F
supplemental
20-F
Pre-IPO filing captured from the SEC submission timeline.
Follows CERT in the pre-IPO sequence.
2024-03-06 · 0001625297-24-000017
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows DRS/A in the pre-IPO sequence.
2023-06-07 · 0001354457-23-000379
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2023-04-27 · 0001628279-23-000159
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2023-03-10 · 0001628279-23-000069
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2023-01-18 · 0001628279-23-000007
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2022-11-22 · 0001628280-22-030683
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after EFFECT.
2022-11-22 · 0001628280-22-030627
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
First tracked pre-IPO filing for this issuer.
2014-12-23 · 9999999995-14-003801
Comparable Deals
20 comparable deals
Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
Vogenx, Inc.
VOGX
same SICrecent IPO
BlossomHill Therapeutics, Inc.
BLSM
same SICrecent IPO
Latigo Biotherapeutics, Inc.
LTGO
same SICrecent IPO
Braveheart Bio, Inc.
BRVE
same SICrecent IPO
Apnimed, Inc.
APMD
same SICrecent IPO
Kardigan, Inc.
KARD
same SICrecent IPO
Parabilis Medicines, Inc.
PBLS
same SICrecent IPO
Seaport Therapeutics, Inc.
SPTX
same SICrecent IPO
Recent News
No recent news stored for this issuer.